Speech-Language Pathologists in Island Park, NY Accepting Medicare

8 Speech-Language Pathologists found. Showing 1 - 8

Maryanne Aneiro, SPEECH PATHOLOGIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 170 Quebec Rd, Island Park, NY 11558 Phone: 516-897-2969

Nicole Angelone Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Lincoln Ave, Island Park, NY 11558 Phone: 516-301-7477

Mrs. Virginia Lee Davis, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 49 Redfield Rd., Island Park, NY 11558 Phone: 516-431-9038

Mrs. Laurie Ellen Goldschlag, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Radcliffe Rd, Island Park, NY 11558 Phone: 516-434-2600

Dr. Laurie R Scimeca, ED.D. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 150 Trafalgar Blvd, Island Park, NY 11558 Phone: 516-431-8169

Mrs. Andrea K Dworkis, M.A. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 98 Madison Ave, Island Park, NY 11558 Phone: 516-330-9812

Gina Marie Moravcik, MASLPCCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 541 Long Beach Rd, Island Park, NY 11558 Phone: 516-840-9574

Ms. Andrea Arce, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4074 Ohio Pl, Island Park, NY 11558 Phone: 516-432-3938

News Archive

Researchers map processes that power health benefits of omega-3 fatty acids

For the first time, researchers at the University of California, San Diego have peered inside a living mouse cell and mapped the processes that power the celebrated health benefits of omega-3 fatty acids. More profoundly, they say their findings suggest it may be possible to manipulate these processes to short-circuit inflammation before it begins, or at least help to resolve inflammation before it becomes detrimental.

New therapeutic targets for malaria

Scientists working on a common antimicrobial compound with antimalarial activity have discovered a range of new therapeutic strategies to combat malaria.

Pfizer announces approval of tofacitinib for treatment of rheumatoid arthritis

Pfizer Inc. announced today that tofacitinib has been approved for the treatment of rheumatoid arthritis in patients who had an inadequate response to existing therapies in several additional countries around the world, including Switzerland, which is the first European country to receive approval.

Nearly one-third of U.S. parents don't know what to expect of infants

Almost one-third of U.S. parents have a surprisingly low-level knowledge of typical infant development and unrealistic expectations for their child's physical, social and emotional growth, according to new research from the University of Rochester.

Read more Medical News

› Verified 4 days ago